M&A Deal Summary

Ampersand Capital Partners Acquires NuvinkaDx

On April 21, 2022, growth capital firm Ampersand Capital Partners acquired life science company NuvinkaDx

Acquisition Highlights
  • This is Ampersand Capital Partners’ 34th transaction in the Life Science sector.
  • This is Ampersand Capital Partners’ 59th transaction in the United States.
  • This is Ampersand Capital Partners’ 2nd transaction in New Hampshire.

M&A Deal Summary
Date 2022-04-21
Target NuvinkaDx
Sector Life Science
Buyer(s) Ampersand Capital Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

NuvinkaDx

Salem, New Hampshire, United States
NuvinkaDx is a global diagnostics company, brings established expertise in immunodiagnostics and molecular diagnostics. NuvinkaDx is based in Salem, New Hampshire.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 70 of 84
Sector (Life Science) 34 of 43
Type (Buyout (LBO, MBO, MBI)) 21 of 23
State (New Hampshire) 2 of 2
Country (United States) 59 of 69
Year (2022) 5 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-21 ALPCO

Salem, New Hampshire, United States

ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-02 Vernal Biosciences

Colchester, Vermont, United States

Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation. Vernal Biosciences is based in Colchester, Vermont.

Buy -
Mergr

Product

Company

Legal